<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Diffusion Pharmaceuticals &#187; Funding</title>
	<atom:link href="http://www.diffusionpharma.com/category/funding/feed" rel="self" type="application/rss+xml" />
	<link>http://www.diffusionpharma.com</link>
	<description></description>
	<lastBuildDate>Mon, 06 Feb 2012 14:39:17 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.1</generator>
		<item>
		<title>Diffusion Pharmaceuticals Closes on $2.2 Million Financing; Plans Clinical Trial In Primary Brain Cancer</title>
		<link>http://www.diffusionpharma.com/progress/closes-on-2-2-million-financing-plans-clinical-trial-in-primary-brain-cancer</link>
		<comments>http://www.diffusionpharma.com/progress/closes-on-2-2-million-financing-plans-clinical-trial-in-primary-brain-cancer#comments</comments>
		<pubDate>Sun, 01 May 2011 15:04:02 +0000</pubDate>
		<dc:creator>Tracey Danner</dc:creator>
				<category><![CDATA[Funding]]></category>
		<category><![CDATA[Progress]]></category>
		<category><![CDATA[clinical trial]]></category>
		<category><![CDATA[fundraising]]></category>
		<category><![CDATA[GBM]]></category>
		<category><![CDATA[glioblastoma multiforme]]></category>
		<category><![CDATA[TSC]]></category>

		<guid isPermaLink="false">http://www.diffusionpharma.com/?p=439</guid>
		<description><![CDATA[CHARLOTTESVILLE, VA – May 1, 2011 – Diffusion Pharmaceuticals LLC, a clinical-stage drug-development company commercializing first-in-class drugs to treat life-threatening unmet medical conditions, today announced that it closed on an additional $2.2 million in private financing during the first quarter of 2011. The financing consisted of convertible notes issued to existing investors. Proceeds will support [...]]]></description>
		<wfw:commentRss>http://www.diffusionpharma.com/progress/closes-on-2-2-million-financing-plans-clinical-trial-in-primary-brain-cancer/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Diffusion Pharmaceuticals One of 45 Virginia Companies to Receive Federal Grant</title>
		<link>http://www.diffusionpharma.com/progress/diffusion-pharmaceuticals-one-of-45-virginia-companies-to-receive-federal-grant</link>
		<comments>http://www.diffusionpharma.com/progress/diffusion-pharmaceuticals-one-of-45-virginia-companies-to-receive-federal-grant#comments</comments>
		<pubDate>Thu, 04 Nov 2010 19:12:46 +0000</pubDate>
		<dc:creator>Tracey Danner</dc:creator>
				<category><![CDATA[Awards]]></category>
		<category><![CDATA[Funding]]></category>
		<category><![CDATA[Progress]]></category>

		<guid isPermaLink="false">http://www.diffusionpharma.com/?p=338</guid>
		<description><![CDATA[“This non-dilutive award will advance our clinical program and aid us in our mission to introduce approved novel and effective therapies as quickly as possible, providing new hope for patients with PAD, cancer and other conditions related to hypoxia,” said David G. Kalergis, CEO, Diffusion Pharmaceuticals.”
]]></description>
		<wfw:commentRss>http://www.diffusionpharma.com/progress/diffusion-pharmaceuticals-one-of-45-virginia-companies-to-receive-federal-grant/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Diffusion Pharmaceuticals LLC Closes on $5.9 Million Financing</title>
		<link>http://www.diffusionpharma.com/progress/diffusion-pharmaceuticals-llc-closes-on-5-9-million-financing</link>
		<comments>http://www.diffusionpharma.com/progress/diffusion-pharmaceuticals-llc-closes-on-5-9-million-financing#comments</comments>
		<pubDate>Fri, 29 Jan 2010 13:00:29 +0000</pubDate>
		<dc:creator>Tracey Danner</dc:creator>
				<category><![CDATA[Funding]]></category>
		<category><![CDATA[Progress]]></category>

		<guid isPermaLink="false">http://www.diffusionpharma.com/?p=168</guid>
		<description><![CDATA[CHARLOTTESVILLE, VA – January 29, 2010 – Diffusion Pharmaceuticals LLC, a clinical-stage drug-development company commercializing first-in-class drugs to treat serious or life-threatening unmet medical conditions, today announced that it closed on $5.9 million in additional private financing during the second half of 2009, bringing the total the company raised in 2009 to $7.1 million. The [...]]]></description>
		<wfw:commentRss>http://www.diffusionpharma.com/progress/diffusion-pharmaceuticals-llc-closes-on-5-9-million-financing/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

